CN Patent

CN103635190B — 治疗方案

Assigned to S1 Pharmaceuticals Inc · Expires 2016-09-07 · 10y expired

What this patent protects

本发明进一步涉及用于治疗受试者中的机能减退的性欲障碍（HSDD）的化合物、药物组合物和方法。

USPTO Abstract

本发明进一步涉及用于治疗受试者中的机能减退的性欲障碍（HSDD）的化合物、药物组合物和方法。

Drugs covered by this patent

pimavanserin-tartrate (PIMAVANSERIN TARTRATE)

Patent Metadata

Patent number: CN103635190B
Jurisdiction: CN
Classification: —
Expires: 2016-09-07
Drug substance claim: No
Drug product claim: No
Assignee: S1 Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.